Menu
Montecito
American Riviera
Loading...
You are here:  Home  >  Central Coast Health Watch  -  Page 2

Dignity Health
Latest

Inogen shares drop despite projected revenue growth

By   /  Tuesday, January 11th, 2022  /  Banking & Finance, Central Coast Health Watch, Earnings, Latest news, South Coast, Technology, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Inogen shares drop despite projected revenue growth

Goleta-based Inogen expects minor revenue growth in the fourth quarter of 2021 but major growth for the full fiscal year, according to preliminary estimates the company released Jan. 10. The portable oxygen concentrator manufacturer expects to see revenue in the range of $75.9 million to $76.9 million for the three months ended December 31, growth Read More →

Read More →
Latest

Sientra shares up after company releases 2021 revenue estimates

By   /  Monday, January 10th, 2022  /  Banking & Finance, Central Coast Health Watch, Earnings, Latest news, South Coast, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Sientra shares up after company releases 2021 revenue estimates

The Goleta-based breast implant manufacturer Sientra expects growth in the fourth quarter of 2021 and estimates its “highest-ever breast products yearly revenue” of up to $81 million for the full year, the company said Jan. 10. Sientra reported that its preliminary unaudited revenue from operations for the fourth quarter of 2021 is expected to be Read More →

Read More →
Latest

Amgen inks drug development deal worth up to $1.9B

By   /  Friday, January 7th, 2022  /  Banking & Finance, Biotech, Central Coast Health Watch, East Ventura County, Latest news, Technology, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen inks drug development deal worth up to $1.9B

Thousand Oaks-based Amgen has reached an agreement with Generate Biomedicines, a Massachusetts-based therapeutics company, to research, discover and create protein therapeutics, the company announced Jan. 6. According to the agreement, Amgen, one of the largest biotech companies in the world, will pay $50 million up front to fund the initial five programs, with a potential Read More →

Read More →
Latest

Our View: Deja vu as 2022 begins, but with some big differences

By   /  Friday, January 7th, 2022  /  Central Coast Health Watch, Editorials, Latest news, Opinion  /  Comments Off on Our View: Deja vu as 2022 begins, but with some big differences

We begin 2022 as we ended 2021, with the newest variant of the virus dominating the headlines. As the Business Times goes to press on its first edition of the year, it is back to the future, as most meetings and live events have moved to virtual. Virtual meetings are a poor substitute for in-person, Read More →

Read More →
Latest

2021: The Year In Review

By   /  Friday, December 31st, 2021  /  Banking & Finance, Biotech, Central Coast, Central Coast Health Watch, Latest news, Technology, Top Stories, Tri-County Economy  /  No Comments

The Dec. 31 print edition of the Pacific Coast Business Times marks our annual Year In Review, featuring the biggest and best stories we published in 2021. Here is a look through our archives at the past year, a year marked by big deals, economic recovery and public health victories, but also by recurring waves Read More →

Read More →
Latest

Hardy prepares to sell swab-free COVID-19 test developed at Cal Poly

By   /  Wednesday, December 22nd, 2021  /  Central Coast, Central Coast Health Watch, Education, Latest news, middle, Subscriber content, Top Stories, Tri-County Economy  /  Comments Off on Hardy prepares to sell swab-free COVID-19 test developed at Cal Poly

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen’s new asthma treatment gets FDA approval

By   /  Wednesday, December 22nd, 2021  /  Banking & Finance, Biotech, Central Coast Health Watch, East Ventura County, Latest news, Subscriber content, Technology, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen’s new asthma treatment gets FDA approval

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →